Wolverine Trading, LLC Medpace Holdings, Inc. Call Options Transaction History

Wolverine Trading, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $801,450 - $1.14 Million	2,500 Added 277.78%	3,400 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $1.64 Million - $1.87 Million	-4,400 Reduced 83.02%	900 $370,000
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $284,870 - $413,310	-1,000 Reduced 15.87%	5,300 $2.14 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $1.43 Million - $1.97 Million	6,300 New	6,300 $1.93 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $597,141 - $921,533	-4,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $584,768 - $729,280	3,200 Added 290.91%	4,300 $942,000
Q3 2021 Nov 12, 2021	SELL	$170.18 - $198.21 $476,504 - $554,988	-2,800 Reduced 71.79%	1,100 $206,000
Q3 2020 Nov 13, 2020	BUY	$92.95 - $130.61 $362,505 - $509,379	3,900 New	3,900 $434,000
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $422,096 - $593,216	-6,200 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$61.71 - $101.95 $684,981 - $1.13 Million	-11,100 Reduced 64.16%	6,200 $465,000
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $511,516 - $704,298	8,200 Added 90.11%	17,300 $1.44 Million
Q2 2019 Aug 20, 2019	SELL	$53.64 - $65.42 $2.39 Million - $2.92 Million	-44,600 Reduced 83.05%	9,100 $595,000
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $2.08 Million - $2.98 Million	42,200 Added 366.96%	53,700 $3.17 Million
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $657,580 - $895,720	-14,000 Reduced 54.9%	11,500 $596,000
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $1.1 Million - $1.63 Million	25,500 New	25,500 $1.53 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.